Navigation Links
Surefire Infusion System Used In Potential New Hunger-Reducing Obesity Treatment -- NIH Funds Johns Hopkins Study

WESTMINSTER, Colo., May 2, 2013 /PRNewswire/ -- Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced that the company's Surefire Infusion System will be used in the development of the first clinically viable microcatheter-based, minimally invasive treatment for obesity as an alternative to bariatric surgery.

The Bariatric Arterial Embolization research at Johns Hopkins Medicine, led by principal investigators, Clifford Weiss , M.D., Assistant Professor of Radiology, and Dara Kraitchman , V.M.D, Ph. D,. FACC, Professor of Radiology, a porcine study, began May 1, 2013 with a $1.3 million grant from the National Institutes of Health (NIH). 

The procedure precisely targets the fundus, the area of the stomach that produces ghrelin or the 'hunger hormone.'   Multiple pharmacological attempts to curb ghrelin, a gastric hormone that stimulates hunger, have been largely unsuccessful. 

The novel Surefire Infusion technology, with its unique expandable antireflux tip, was chosen for its ability to:

  • Improve targeting
  • Prevent reflux into healthy, non-target tissue
  • Achieve deeper penetration of the X-Ray visible embolic beads (XEBs) developed for this study

"Bariatric Embolization will be the world's first image-guided, minimally invasive procedure targeting obesity that could be a viable alternative to bariatric surgery," said Aravind Arepally , M.D., Surefire Medical's Chief Scientific Officer and former Clinical Director for the Center for Bioengineering Innovation and Design at Johns Hopkins.  "In our prior work, which showed that this procedure may be as effective as bariatric surgery in curbing hunger, we realized that precise delivery into the gastric fundus was critical.   The Surefire's unique properties enable the more highly targeted, precise delivery vital for development of a new obesity treatment."

About Surefire Medical
Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop innovative infusion systems for the interventional radiology and interventional oncology markets.  Surefire's infusion systems are designed to precisely deliver embolic agents through a unique microcatheter with an expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow in order to maximize targeted delivery, minimize reflux and reduce damage to healthy tissue.  For more information, please visit

SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
2. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
3. Christopher Mennone Joins Surefire Medical Team As International Business Director
4. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
5. Study: Surefire Medicals Technology Improves Delivery Of Embolics In Cancer Treatment
6. Aperture Health, Inc. focuses in on IV Therapy Value Creation and the Merger and Acquisition Activities in the Home Infusion Therapy Sector.
7. CareFusion Expands Infusion Pump Interoperability
8. Global Infusion Pumps Market 2011-2015
9. Riordan Lewis & Haden
10. Equity Partners Acquires Nutritional Therapy Provider DCRX Infusion
11. Hospira and Q Core Medical Sign International Distribution Agreement for Sapphire Infusion System
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ) ... Administration of High Viscosity Drugs" report to ... announced the addition of the "Self Administration ... offering. --> Research and Markets ( ... "Self Administration of High Viscosity Drugs" ...
(Date:11/25/2015)... -- The total global healthcare industry is expected to grow at ... America has the highest projected growth at 12.7%, ... ), is second with growth projected at 11.5%. ... expenditure. In 2013-2014, total government funded healthcare was nearly 68%. ... 41.2% in 2013-2014. In real terms, out of pocket expenditure ...
(Date:11/25/2015)... , Nov. 25, 2015 On Tuesday, ... federal bellwether trial against Wright Medical Technology, Inc. ... their Conserve metal-on-metal hip implant device, awarded $11 ... a two week trial and three days of ... hip device was defectively designed and unreasonably dangerous, ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD and Cambridge Memorial ... in the Waterloo region. Using the Ocean Platform, family physicians can now order ... electronic medical record (EMR) without the need for redundant patient entry or an ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... process, participated in the 61st annual Employee Benefits Conference. The Employee Benefits Conference ... Sunday, November 8th through Wednesday, November 11th, 2015. The conference was held at ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... for all, Water For Empowerment ™ attracts volunteers together who want to ... by empowering women as key stakeholders in the process. The non-profit launched its ...
(Date:11/25/2015)... Las Vegas, NV (PRWEB) , ... November 25, 2015 , ... ... Nevada, invites patients to learn more about hair loss treatment with the Capillus272™ Pro ... women an effective solution for thicker and fuller hair, without the need for surgery, ...
(Date:11/25/2015)... FL (PRWEB) , ... November 25, 2015 , ... ... center, is encouraging people across the country to celebrate their sobriety and show ... people to post “before and after” photos this Thanksgiving with the hashtag #FacesOfGratitude ...
Breaking Medicine News(10 mins):